FENNEC PHARMACEUTICALS INC

For the period ended Dec 31, 2023. Filed Mar 29, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 29, 2024

FENC$10.83+10.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

PART I	1

Item 1.	Business	4

Item 1A.	Risk Factors	24

Item 1B.	Unresolved Staff Comments	63

Item 1C.	Cybersecurity	63

Item 2.	Properties	65

Item 3.	Legal Proceedings	65

Item 4.	Mine Safety Disclosures	66

PART II	66

Item 5.	Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer’s Purchases of Equity Securities	66

Item 6.	Reserved	73

Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	73

Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	81

Item 8.	Financial Statements and Supplementary Data	81

Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	81

Item 9A.	Controls and Procedures	81

Item 9B.	Other Information	83

Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	83

PART III	84

Item 10.	Directors, Executive Officers and Corporate Governance	84

Item 11.	Executive Compensation	87

Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	91

Item 13.	Certain Relationships and Related Transactions and Director independence	92

Item 14.	Principal Accounting Fees and Services	93

PART IV	94

Item 15.	Exhibits and Financial Statement Schedules	94


SIGNATURES	97

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents